Aceto reported -10827000 in Operating Profit for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Acasti Pharma ACST:US C$ -2.3M 5.73M
Aceto ACET:US -10827000 10.53M
Agile Therapeutics AGRX:US -16651000 429K
Glaxosmithkline GSK:US $ 1675M 18M
Idera Pharmaceuticals IDRA:US $ -7.56M 2.47M
Merk MRK:US $ 1497M 1517M
Novartis NVS:US $ 3479M 1064M
Pain Therapeutics PTIE:US $ -5138000 1.6M
Pfizer PFE:US $ 5914M 397M
Prestige Brands PBH:US $ 91.34M 32.73M